IktosAI

Artificial intelligence for new drug design

[IktosAI @IktosAI]

Come see @Iktos present 4/25 at @MassBio 2024 Align Summit w/ insights by @McKinsey & @LocustWalkPtrs. Register here: https://t.co/7yLmTocv7q #AlignSummit24

[IktosAI @IktosAI]

@IktosAI and @ElsLifeSciences are thrilled to partner together to deliver a predictive #retrosynthesis and synthetic accessibility platform that accelerates chemistry research for drug discovery. Learn more: https://t.co/aecXuKSeDY
#Reaxys #drugdiscovery #DMTAcycle #AI

[IktosAI @IktosAI]

Seasons greetings from @IktosAI team
https://t.co/vM6UBP4XxS

[IktosAI @IktosAI]

@IktosAI team will be at the JPM 2023

https://t.co/WIOtvHJbDN

[IktosAI @IktosAI]

In an interview with PharmaShots, Dr. Sree Vadlamudi, Vice president, Head of Business Development EU and RoW at @IktosAI, shared his views on the role of AI in shaping the pharma & biotech industry.

Read the interview here: https://t.co/Swl9PmSjUr

https://t.co/l7QDnxCCAl

[IktosAI @IktosAI]

Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of SLAS Europe 2022 coverage.
https://t.co/IpVPnlf0jE

[IktosAI @IktosAI]

Our CEO & Co-Founder, Yann Gaston-Mathe's interview on Spaya™ has been published by Medicen in their 2022 report. Follow the link for the full report: https://t.co/ytXpHvxlVN
https://t.co/LwektfCOSS

[IktosAI @IktosAI]

@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development.
https://t.co/3a9cjHWWSD

[IktosAI @IktosAI]

@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development.
https://t.co/3a9cjHWWSD

[IktosAI @IktosAI]

https://t.co/9dGG1H5HTW

[IktosAI @IktosAI]

https://t.co/1nnmLOcQEx

[IktosAI @IktosAI]

https://t.co/eZcVjPgRsP

[IktosAI @IktosAI]

https://t.co/QdFakVZB6R

[IktosAI @IktosAI]

https://t.co/vqHMdxGZNX

[IktosAI @IktosAI]

https://t.co/AdH5z6qN2C

[IktosAI @IktosAI]

https://t.co/YH5z1AUBNA

[IktosAI @IktosAI]

https://t.co/gYTvwzk6Zl

[IktosAI @IktosAI]

@IktosAI team is thrilled to announce their latest collaboration agreement with Galapagos

Iktos, Makya™, Spaya™

https://t.co/eomXOee2mM

[IktosAI @IktosAI]

@IktosAI team is very pleased to share the news about our latest collaboration agreement with Zealand Pharma pharma to develop AI technology for peptide drug design

https://t.co/mDY7U5olHh

[IktosAI @IktosAI]

Interested to know more about Makya? Have a look at out new site https://t.co/dgHv67geGR

@IktosAI , Makya™, Spaya™

https://t.co/RlntbLIBl3